Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA

Virology

Volumn 273, Issue 1, 2000, Pages 67-79

  Lockridge, Kristen M ^a   Chien, May ^a   Dean, Gregg A ^c   Stefano Cole, Kelly ^d   Montelaro, Ronald C ^d   Luciw, Paul A ^b   Sparger, Ellen E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ANIMAL CELL; ARTICLE; CAT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELETION MUTANT; FELINE IMMUNODEFICIENCY VIRUS; GENE DELETION; IMMUNE DEFICIENCY; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; PROVOCATION; VACCINATION;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; RNA VIRUSES;

EID: 0034691524     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0395     Document Type: Article

References (75)

1. Almond N., Kent K., Cranage M., Rud E., Clarke B., Stott E. J. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet. 345:1995;1342-1344.
2. Baba T. W., Jeong Y. S., Penninck D., Bronson R., Greene M. F., Ruprecht R. M. Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1995;1820-1825.
3. Baba T. W., Liska V., Khimani A. H., Ray N. B., Dailey P. J., Penninck C., Bronson R., Greene M. F., McClure H. M., Martin L. N., Ruprecht R. M. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5:1999;194-203.
4. Barlough J. E., Ackley C. D., George J. W., Levy N., Acevedo R., Moore P. F., Rideout B. A., Cooper M. D., Pedersen N. C. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: Comparison of short-term and long-term infections. J. Acquir. Immune Defic. Syndr. 4:1991;219-227.
5. Barlough J. E., North T. W., Oxford C. L., Remington K. M., Dandekar S., Ellis M. N., Pedersen N. C. Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants. Antiviral Res. 22:1993;259-272.
6. Beatty J. A., Willett B. J., Gault E. A., Jarrett O. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70:1996;6199-6206.
7. Beebe A. M., Dua N., Faith T. G., Moore P. F., Pedersen N. C., Dandekar S. Primary stage of feline immunodeficiency virus infection: Viral dissemination and cellular targets. J. Virol. 68:1994;3080-3091.
8. Beer B., Baier M., Zur Megene J., Norley S., Kurth R. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African geen monkeys in the absence of detectable vaccine vairus replication in vivo. Proc. Natl. Acad. Sci. USA. 94:1997;4062-4067.
9. Bishop S. A., Stokes C. R., Gruffydd-Jones T. J., Whiting C. V., Humphries J. E., Osborne R., Papanastasopoulou M., Harbour D. A. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: Protection, breakthrough and specificity of response. Vaccine. 14:1996;1243-1250.
10. Borman A. M., Quillent C., Charneau P., Dauguet C., Clavel F. Human immunodeficiency virus type 1 vif- mutant particles from restrictive cells: Role of vif in correct particle assembly and infectivity. J. Virol. 69:1995;2058-2067.
11. Borrow P., Lewicki H., Hahn B. H., Shaw G. M., Oldsone M. B. A. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:1994;6103-6110.
12. - human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71:1997;2473-2477.
13. Brown W. C., Bissey L., Logan K. S., Pedersen N. C., Elder J. H., Collison E. W. Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J. Virol. 65:1991;3359-3364.
14. Bucci J. G., English R. V., Jordan H. L., Childers T. A., Tompkins M. B., Tompkins W. A. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J. Infect. Dis. 177:1998;18-25.
15. Chattergoon M., Boyer J., Weiner D. B. Genetic immunization: A new era in vaccines and immune therapeutics. FASEB J. 11:1997;753-763.
16. Cole K. S., Rowles J. L., Murphey-Corb M., Clements J. E., Unangst T., Robinson J., Desrosiers R. C., Wyand M. S., Montelaro R. C. Evolution of envlope-specific antibody responses in monkeys experimentally infected or immunized with SIV and its association with the devlopment of protective immunity. J. Virol. 71:1997;5069-5079.
17. Dandekar S., Beebe A. M., Barlough J., Phillips T., Elder J., Torten M., Pedersen N. Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J. Virol. 66:1992;4040-4049.
18. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 253:1991;1938-1941.
19. Dean G. A., Himathongkham S., Sparger E. E. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J Virol. 73:1999;2596-2603.
20. Dean G. A., Reubel G. H., Moore P. F., Pedersen N. C. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J. Virol. 70:1996;5165-5169.
21. Desrosiers R. C., Lifson J. D., Gibbs J. S., Czajak S. C., Howe A. Y. M., Arthur L. O., Johnson R. P. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1998;1431-1437.
22. Diehl L. J., Mathiason-DuBard C. K., O'Neil L. L., Hoover E. A. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J. Virol. 69:1995;2328-2332.
23. Dow S. W., Mathiason C. K., Hoover E. A. In vivo monocyte tropism of pathogenic feline immunodeficiency viruses. J. Virol. 73:1999;6852-6861.
24. English R. V., Johnson C. M., Gebhard D. H., Tompkins M. B. In vivo lymphocyte tropism of feline immunodeficiency virus. J.Virol. 67:1993;5175-5186.
25. Flynn J. N., Hosie M. J., Rigby M. A., Mackkay n., Cannon C. A., Dunsford T., Neil J. C., Jarrett O. Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccinantion. Vaccine. 18:2000;1118-1132.
26. Flynn J. N., Keating P., Hosie M. J., Mackett M., Stephens E. B., Beatty J. A., Neil J. C., Jarrett O. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J. Immunol. 157:1996;3658-3665.
27. Fouchier R. A., Simon J. H., Jaffe A. B., Malim M. H. Human immunodeficiency virus type 1 vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70:1996;8263-8269.
28. Gabuzda D. H., Li H., Lawrence K., Vasir B. S., Crawford K., Langhoff E. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J. Acquir. Immune Defic. Syndr. 7:1994;908-915.
29. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., Silvera P., Dennis M., Corcoran T., Stott J., McMichael A., Gotch F. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1996;1167-1173.
30. Gauduin M., Glickman R. L., Means R., Johnson R. P. Inhibition of simian immundeficiency virus (SIV) replication by CD8+ T lymphocytes from macaques immunized with live attenuated SIV. J. Virol. 72:1998;6315-6324.
31. George J. W., Pedersen N. C., Higgins J. The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res. Hum. Retroviruses. 9:1993;897-905.
32. Harmache A., Russo P., Guiguen F., Vitu C., Vignoni M., Bouyac M., Hieblot C., Pepin M., Vigne R., Suzan M. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology. 224:1996;246-255.
33. Hosie M. J., Flynn J. N. Feline immunodeficiency virus vaccination: Characterization of the immune correlates of protection. J. Virol. 70:1996;7561-7568.
34. Hosie M. J., Flynn J. N., Rigby M. A., Cannon C., Dunsford T., Mackay N. A., Argyle D., Willett B. J., Miyazawa T., Onions D. E., Jarrett O., Neil J. C. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral anitbodies. J. Virol. 72:1998;7310-7319.
35. Hosie M. J., Osborne R., Yamamoto J. K., Neil J. C., Jarrett O. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1995;1253-1255.
36. Inoshima Y., Kohmoto M., Ikeda Y., Yamada H., Kawaguchi Y., Tomonaga K., Miyazawa T., Kai C., Umemura T., Mikami T. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol. 70:1996;8518-8526.
37. Jeng C. R., English R. V., Childers T., Tompkins M. B., Tompkins W. A. F. Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus. J. Virol. 70:1996;2474-2480.
38. Johnson C. M., Torres B. A., Koyama H., Yamamoto J. K. FIV as a model for AIDS vaccination. AIDS Res.Hum. Retroviruses. 10:1994;225-228.
39. Lahm H. W., Stein S. Characterization of recombinant human IL-2 with micromethods. J. Chromatogr. 326:1985;357-361.
40. Letvin N., Lord C. I., King N. W., Wyand M. S., Myrick K. V., Haseltine W. A. Risks of handling HIV. Nature. 349:1991;573.
41. Lockridge K., Himathongkham S., Sawai E. T., Chein M., Sparger E. E. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology. 261:1999;25-30.
42. Matteucci D., Pistello M., Mazzetti P., Giannecchini S., Mauro D. D., Lonetti I., Zaccaro L., Pollera C., Specter S., Bendinelli M. Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: Protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted. J. Virol. 71:1997;8368-8376.
43. Mazzoli S., Trabattoni D., Lo Caputo S., Piconi S., Ble C., Meacci F., Ruzzante S., Salvi A., Semplici F., longhi R., Fusi M. L., Tofani N., Biasin M., Villa M. L., Mazzotta F., Clerici M. HIV-specific mucosal and cellular immunity in HIV-seonegative partners of HIV-seropositive individuals. Nat. Med. 3:1997;1250-1257.
44. Pedersen N. C., Ho E. W., Brown M. L., Yamamoto J. K. Isolation of a T-lymphotropic virus from domestic cats with immunodeficiency-like syndrome. Science. 235:1987;790-793.
45. Phillips T. R., Talbott R. L., Lamont C., Muir S., Lovelace K., Elder J. H. Comparison of two host cell range variants of feline immunodeficiency virus (FIV). J. Virol. 64:1990;4605-4613.
46. Portis J. L., McAtee F. J., Kayman S. C. Infectivity of retroviral DNA in vivo. J. Acquir. Immune Defic. Syndr. 5:1992;1272-1273.
47. Reimann K. A., Tenner-Racz K., Racz P., Montefiori D. C., Yasutomi Y., Lin W., Ransil B. J., Letvin N. L. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:1994;2362-2370.
48. Rigby M. A., Hosie M. J., Willet B. J., Mackay N., McDonald M., Cannon C., Dunsford T., Jarrett O., Neil J. C. Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Res. Hum. Retroviruses. 13:1997;405-412.
49. Robinson H. L., Montefiori D. c., Johnson R. P., Manson K. H., Kalish M. L., Lifson J. D., Rizvi T. A., Lu S., Hu S. L., Mazzara G. P., Panicali D. L., Herndon J. G., Glickman R. A. C. M., Lydy S. L., Wyand M. S., McClure H. M. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat. Med. 5:1999;526-534.
50. Robinson J. E., Holton D., Liu J., Mc Murdo H., Murciano A., Gohd R. A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A. J. Immunol. Methods. 132:1990;63-71.
51. Rosenberg E. S., Billingsley J. M., Caliendo A. M., Boswell S. L., Sax P. E., Kalams S. A., Walker B. D. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 278:1997;1447-1450.
52. Sakai H., Shibata R., Sakuragi J.-I., Sakurage S., Kawamura M., Adachi A. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1993;1663-1666.
53. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
54. Schmitz J. E., Kuroda M. J., Santra S., Sasseville V. G., Simon M. A., Lifton M. A., Racz P., Tenner-Racz K., Dalesandro M., Sacallon B. J., Ghrayeb J., Forman M. A., Montefiori D. C., Rieber E. P., Letvin N. L., Reimann K. A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283:1999;857-860.
55. Shacklett B. L., Luciw P. A. Analysis of the vif gene of feline immunodeficiency virus. Virology. 204:1994;860-867.
56. Shimojima M., Miyazawa T., Kohmoto M., Ikeda Y., Nishimura Y., Maeda K., Tohya Y., Mikami T. Expansion of CD8 alpha+beta- cells in cats infected with feline immunodeficiency virus. J. Gen. Virol. 79:1998;91-94.
57. Siebelink K. H. J., Chu I.-H., Rimmelzwaan G. F., Weijer K., Herwijnen R. V., Knell P., Egberink H. F., Bosch M. L., Osterhaus A. D. M. E. Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res. Hum. Retroviruses. 6:1990;1373-1378.
58. Simon J. H. M., Malim M. H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein compleses. J. Virol. 70:1996;5297-5305.
59. Song W., Collisson E. W., Billingsley P. M., Brown W. C. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J. Virol. 66:1992;5409-5417.
60. Sparger E. E., Louie H., Ziomeck A. M., Luciw P. A. Infection of cats by injection with DNA of a feline Immunodeficiency virusmolecular clone. Virology. 238:1997;157-160.
61. Sparger E. E., Shacklett B. L., Renshaw-Gegg L., Barry P. A., Pedersen N. C., Elder J. H., Luciw P. A. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology. 205:1994;546-553.
62. Talbott R. L., Sparger E. E., Lovelace K. M., Fitch W. M., Pedersen N. C., Luciw P. A., Elder J. H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;5743-5747.
63. Tellier M. C., Soos J., Pu R., Pollock D., Yamamoto J. K. Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines. Vet. Microbiol. 57:1997;1-11.
64. Tomonaga K., Norimine J., Shin Y.-S., Fukasawa M., Miyazawa T., Adachi A., Toyosaki T., Kawaguchi Y., Kai C., Mikami T. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66:1992;6181-6185.
65. vonSchwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type I proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
66. Willems L., Poretelle D., Kerkhofs P., Chen G., Burny A., Mammerickx M., Kettmann R. In vivo transfection of bovine leukemia provirus Into sheep. Virology. 189:1992;775-785.
67. Willet B. J., Picard L., Hosie M. J., Turner J. D., Adema K., Clapham P. R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71:1997;6407-6415.
68. Willett B. J., Hosie M. J., Dunsford T. H., Neil J. C., Jarrett O. Productive infection of T-Helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS. 5:1991;1469-1475.
69. Woo J. C., Dean G. A., Pedersen N. C., Moore P. F. Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats. J. Virol. 71:1997;8632-8641.
70. Wyand S. M., Manson K. H., Garcia-Moll M., Montefiori D., Desrosiers R. C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:1996;3724-3733.
71. Yamamoto J. K., Hohdatsu T., Olmsted R. A., Pu R., Louie H., Zochlinski H. A., Acevedo V., Johnson H. M., Soulds G. A., Gardner M. B. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:1993;601-605.
72. Yamamoto J. K., Okuda T., Ackley C. D., Louie H., Pembroke E., Zochlinski H., Munn R. J., Gardner M. B. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retroviruses. 7:1991;911-922.
73. Yamamoto J. K., Sparger E., Ho E. W., Andersen P. R., O'Connor T. P., Mandell C. P., Lowenstine L., Munn R., Pedersen N. C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Veter. Res. 49:1988;1246-1258.
74. Yang O. O., Kalams S. A., Trocha a., Cao H., Luster a., Johnson R. P., Walker B. D. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:1997;3120-3128.
75. Yasutomi Y., Reimann K. A., Lord C., Miller M. E., Letvin N. L. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1993;1707-1711.